Skip to main content
SpringerLink
Log in

Methodology for the control of intracranial pressure with hypertonic mannitol

  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

The response to intravenous bolus administrations and continuous infusions of hypertonic mannitol to control elevated (> 25 torr) intracranial pressure (ICP) is presented. Sixty patients received 120 bolus infusions of mannitol (0.18–2.5 g/kg/ dose) with a prompt peak reduction at 44 minutes (range 18 to 120 minutes). There was no relationship between dosage and rapidity of peak response. All administrations of 1.0 g/kg/dose, or higher, consistently reduced ICP 10% or more from control values, but dosages below 1 gm/kg/dose did not always reduce ICP. Return to control ICP following mannitol was unpredictable, and was related to the initial ICP and the volume of fluid replacement. A continuous infusion of mannitol was administered to maintain ICP below 25 torr in 18 patients. This infusion ranged from 6 to 100 hours (×28.8±28.9 hours) and required a total dosage of 2–20 mg/kg, and was successful in 16 of the 18 patients. Emphasis is placed on close observation of the patient's serum osmolality and electrolytes during therapy, as well as quality and magnitude of replacement. No set rules are given for control of ICP, but a guideline is made to meet the individual patient's requirements.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aviram, A., Pfan, A., Czaczkes, J. W., Ulman, J. D., Hyperosmolality with hyponatremia caused by inappropriate administration of mannitol. Amer. J. Med.42 (1967), 648–650.

    PubMed  Google Scholar 

  2. Bakay, L., Crawford, J. D., White, J. C., The effects of intravenous fluids on cerebrospinal fluid pressure. Surg. Gynec.99 (1954), 48–52.

    Google Scholar 

  3. Becker, D. P., Vries, J. K., The alleviation of increased intracranial pressure by the chronic administration of osmotic agents. In: ICP, pp. 310–315 (Brock, M., Dietz, H., eds.). Berlin-Heidelberg-New York: Springer. 1972.

    Google Scholar 

  4. Becker, D. P., Vries, J. K., Young, H. F., Ward, J. D., Controlled cerebral perfusion pressure and ventilation in human mechanical injury: prevention of progressive brain swelling. In: ICP II, pp. 480–484 (Lundberg, N., Ponten, E., Brock, M., eds.). Berlin-Heidelberg-New York: Springer. 1975.

    Google Scholar 

  5. Beks, J. W. F., Groen, A., Huizinga, T., Noordhoek, K. H. N., Smit, J. M., Walter, W. G., Effects of intravenously administered hypertonic urea solution. Acta Neurochir. (Wien)13 (1965), 1–10.

    Google Scholar 

  6. Beks, J., ter Weeme, C., The influence of urea and mannitol on increased intraventricular pressure in cold-induced cerebral edema. Acta Neurochir. (Wien)16 (1967), 97–107.

    Google Scholar 

  7. Bruce, D. A., Langfitt, T. W., Miller, J. D., Schutz, H., Vapalahti, M. P., Stanek, A., Goldberg, H. I., Regional cerebral blood flow, intracranial pressure, and brain metabolism in comatose patients. J. Neurosurg.38 (1973), 131–144.

    PubMed  Google Scholar 

  8. Bullock, L. T., Gregersen, M. I., Kinney, R., The use of hypertonic sucrose solution intravenously to reduce cerebrospinal fluid pressure without a secondary rise. Amer. J. Physiol.112 (1935), 82–96.

    Google Scholar 

  9. Clasen, R., Cooke, P., Pandolfi, S., Carnecki, G., Bryan, G., Hypertonic urea in experimental cerebral edema. Arch. Neurol. (Chicago)12 (1965), 424–434.

    Google Scholar 

  10. Clasen, R. A., Prouty, R. R., Bingham, W. G., Martin, F. A., Hass, G. M., Treatment of experimental cerebral edema with intravenous hypertonic glucose, albumin, and dextran. Surg. Gynec. Obstet.104 (1957), 591–606.

    PubMed  Google Scholar 

  11. Collice, M., Rossanda, M., Bedusehi, A., Porta, M., Management of head injury by means of ventricular fluid pressure monitoring. In: ICP III, pp. 101–109 (Beks, J. W. F., Bosch, D. A., Brock, M., eds.). Berlin-Heidelberg-New York: Springer. 1976.

    Google Scholar 

  12. Einspruch, B., Clark, K., Further studies on the effectiveness of agents used to lower intracranial pressure. J. Neurosurg.23 (1965), 45–48.

    PubMed  Google Scholar 

  13. Fishman, R. A., Effects of isotonic intravenous solutions on normal and increased intracranial pressure. Arch. Neurol. Psychiat.70 (1953), 350–360.

    Google Scholar 

  14. Fremont-Smith, F., Forbes, H. S., Intra-ocular and intracranial pressure: an experimental study. Arch. Neurol. Psychiat.18 (1927), 550–564.

    Google Scholar 

  15. Goluboff, B., Shenkin, H., Hoft, H., The effects of mannitol and urea on cerebral hemodynamics and cerebrospinal fluid pressure. Neurology (Minneap.)14 (1964), 891–898.

    Google Scholar 

  16. Irvine, M. D., Administration of urea for reduction of intracranial and intraocular pressure. Amer. J. Ophthal.49 (1960), 164–166.

    PubMed  Google Scholar 

  17. Jaird, M., Andersen, J., The effect of urea on cerebrospinal fluid pressure in monkeys before and after bilateral nephrectomy. J. Lab. Clin. Med.53 (1959), 484–489.

    PubMed  Google Scholar 

  18. James, H. E., Analysis of therapeutic modalities for head injured children. Child's Brain5 (1979), 263–271.

    PubMed  Google Scholar 

  19. James, H. E., Bruce, D. A., Welsh, F., Cytotoxic edema produced by 6-aminonicotinamide and its response to therapy. Neurosurgery3 (1978), 196–200.

    PubMed  Google Scholar 

  20. James, H. E., Bruno, L., Shapiro, H. M., Levitt, J. D., Aidinis, S., Langfitt, T. W., Methodology for intraventricular and subarachnoid continuous recording of intracranial pressure in clinical practice. Acta Neurochir. (Wien)33 (1976), 45–51.

    Google Scholar 

  21. James, H. E., Harbaugh, R. D., Marshall, L. F., Shapiro, H. M., Laurin, R., Multiple therapeutic modalities in experimental vasogenic edema. In press.

  22. James, H. E., Langfitt, T. W., Kumar, V. S., Ghostine, S. Y., Treatment of intracranial hypertension: Analysis of 105 consecutive, continuous recordings of intracranial pressure. Acta Neurochir. (Wien)36 (1977), 189–200.

    Google Scholar 

  23. James, H. E., Langfitt, T. W., Kumar, V. S., Analysis of the response to therapeutic measures to reduce intracranial pressure in head injured patients. J. Trauma16 (1976), 437–441.

    PubMed  Google Scholar 

  24. Javid, M., Gilboe, D., Cesario, T., The rebound phenomenon and hypertonic solutions. J. Neurosurg. (1964), 1059–1066.

  25. Johnston, I. H., Harper, A. M., The effect of mannitol on cerebral blood flow: An experimental study. J. Neurosurg.36 (1973), 461–471.

    Google Scholar 

  26. Johnston, I. H., Paterson, A., Harper, A. M., Jennett, W. B., The effect of mannitol on intracranial pressure and cerebral blood flow. In: ICP, pp. 176–180 (Brock, M., Dietz, H., eds.). Berlin-Heidelberg-New York: Springer. 1972.

    Google Scholar 

  27. Kullberg, G., Sundbarg, G., Reduction of raised intracranial pressure following infusion of mannitol. In: ICP III, pp. 224–227 (Beks, J. W. F., Bosch, D. A., Brock, M., eds.). Berlin-Heidelberg-New York: Springer. 1976.

    Google Scholar 

  28. Langfitt, T. W., Possible mechanisms of action of hypertonic urea in reducing intracranial pressure. Neurol.11 (1961), 196–209.

    Google Scholar 

  29. Leech, P., Miller, J. D., Intracranial volume-pressure relationships during experimental brain compression in primates. 3. Effects of mannitol and hyperventilation. J. Neurol. Neurosurg. Psychiatry37 (1974), 1105–1111.

    PubMed  Google Scholar 

  30. Marshall, L. F., Smith, R. W., Rauscher, L. A., Shapiro, H. M., Mannitol dose requirements in brain-injured patients. J. Neurosurg.48 (1978), 169–172.

    PubMed  Google Scholar 

  31. Masserman, J. H., Effects of intravenous administration of hypertonic solutions of dextrose. With special reference to the cerebrospinal fluid pressure. J. A. M. A.102 (1934), 2084–2086.

    Google Scholar 

  32. McQueen, J. D., Jeanes, L. D., Dehydration and rehydration of the brain with hypertonic urea and mannitol. J. Neurosurg.21 (1964), 118–128.

    PubMed  Google Scholar 

  33. Miller, J. D., Leech, P., Effects of mannitol and steroid therapy on intracranial volume-pressure relationships in patients. J. Neurosurg.42 (1975), 274–281.

    PubMed  Google Scholar 

  34. Pappius, H. M., Dayes, L. A., Hypertonic urea: Its effect on the distribution of water and electrolytes in normal and edematous brain tissue. Arch. Neurol.13 (1965), 395–402.

    PubMed  Google Scholar 

  35. Prill, A., Volles, E., Dahlman, W., Stabilization and disturbance of csmoregulation in the cerebrospinal fluid. In: ICP, pp. 303–308 (Brock, M., Dietz, H., eds.). Berlin-Heidelberg-New York: Springer. 1972.

    Google Scholar 

  36. Reed, D., Woodbury, D., Effect of urea and acetazolamide on brain volume and cerebrospinal fluid pressure. J. Physiol.164 (1962), 265–273.

    PubMed  Google Scholar 

  37. Reed, D. J., Woodbury, D. M., Effect of hypertonic urea on cerebrospinal fluid pressure and brain volume. J. Physiol.164 (1962), 252–264.

    PubMed  Google Scholar 

  38. Scewczykowski, J., Slivka, S., Kunicki, A., Korsack-Slivka, J., Dziduszko, J., Dytko, P., Augustyniak, B., Computer-assisted analysis of intraventricular pressure after mannitol administration. J. Neurosurg.43 (1975), 136–141.

    PubMed  Google Scholar 

  39. Shenkin, H. A., Bezier, H. S., Bouzarth, W. F., Restricted fluid intake. J. Neurosurg.45 (1976), 432–436.

    PubMed  Google Scholar 

  40. Shenkin, H. A., Goluboff, B., Haft, H., The use of mannitol for the reduction of intracranial pressure in intracranial surgery. J. Neurosurg.19 (1962), 897–901.

    PubMed  Google Scholar 

  41. Silber, S. J., Thompson, N., Mannitol-induced central nervous system toxicity in renal failure. Invest. Urol.9 (1972), 310–312.

    PubMed  Google Scholar 

  42. Sotos, J. F., Dodge, P. R., Meara, P., Talbot, N. B., Studies in experimental hypertonicity. Peds.26 (1960), 925–928.

    Google Scholar 

  43. Stuart, F. P., Torres, E., Fletcher, D., Moore, F. D., Effects of repeated and massive mannitol infusion in the dog. Structural and functional changes in kidney and brain. Amer. Surg.172 (1970), 190–204.

    Google Scholar 

  44. Troupp, H., Valtonen, S., Vapalahti, M., Intraventricular pressure after administration of dehydrating agents to severely brain injured patients: Is there a rebound phenomenon? Acta Neurochir. (Wien)24 (1971), 89–95.

    Google Scholar 

  45. Weed, L. H., McKibben, P. S., Pressure changes in the cerebrospinal fluid following intravenous injection of solutions of various concentrations. Amer. J. Physiol.48 (1919), 512–530.

    Google Scholar 

  46. Wise, B. L., Effects of infusion of hypertonic mannitol on electrolyte balance and on osmolarity of serum and cerebrospinal fluid. J. Neurosurg.20 (1963), 961–967.

    PubMed  Google Scholar 

  47. Wise, B. L., Chater, N., The value of hypertonic mannitol solution in decreasing brain mass and lowering cerebrospinal fluid pressure. J. Neurosurg.19 (1962), 1038–1043.

    PubMed  Google Scholar 

Download references

Author information

Author notes

  1. H. E. James

    Present address: Division of Neurosurgery, University of California Medical Centre, San Diego, Calif., USA

Authors and Affiliations

    Authors
    1. H. E. James
      View author publications

      You can also search for this author in PubMed Google Scholar

    Rights and permissions

    Reprints and permissions

    About this article

    Cite this article

    James, H.E. Methodology for the control of intracranial pressure with hypertonic mannitol. Acta neurochir 51, 161–172 (1980). https://doi.org/10.1007/BF01406742

    Download citation

    • Issue Date:

    • DOI: https://doi.org/10.1007/BF01406742

    Keywords

    Search

    Navigation